Welcome to LookChem.com Sign In|Join Free

CAS

  • or

50289-20-8

50289-20-8

Post Buying Request

50289-20-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50289-20-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 50289-20-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,2,8 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 50289-20:
(7*5)+(6*0)+(5*2)+(4*8)+(3*9)+(2*2)+(1*0)=108
108 % 10 = 8
So 50289-20-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H10N2S/c7-5-6(8)1-3-9-4-2-6/h1-4,8H2

50289-20-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-aminothiane-4-carbonitrile

1.2 Other means of identification

Product number -
Other names 4-aminotetrahydrothiopyran-4-ylcarbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50289-20-8 SDS

50289-20-8Relevant articles and documents

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

-

Paragraph 00282, (2013/04/24)

The invention provides certain 2-pyridyl carboxamide-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A and B are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 72, (2008/06/13)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLINONE DERIVATIVES

-

, (2008/06/13)

Novel imidazolinone derivatives of formula (I), which are useful as angiotensin II antagonists, are disclosed: STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 50289-20-8